Purchases and Sales Made in Q2 2021 in Syros Pharmaceuticals, Inc. (SYRS)
This table provides information about the institutional ownership of Syros Pharmaceuticals, Inc. (SYRS) during Q2 2021. The information is specifically focused on institutions that hold shares of Syros Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2021
Q2 2021
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-625K- 90.51% |
$3.13M - $4.67M
|
65.5K
$140K
|
|
|
Aug 09, 2021
Q2 2021
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-5.04MClosed |
$25.3M - $37.7M
|
0
$0
|
|
|
Aug 02, 2021
Q2 2021
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-5.17MClosed |
$25.9M - $38.6M
|
0
$0
|
|
|
Aug 05, 2021
Q2 2021
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-7.71MClosed |
$38.6M - $57.7M
|
0
$0
|